Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models

Pia M. Challita-Eid, Daulet Satpayev, Peng Yang, +21

Cancer Research

In Vitro and In Vivo Evaluation of Cysteine and Site Specific Conjugated Herceptin Antibody-Drug Conjugates

Dowdy Jackson, John Atkinson, Claudia Guevara, +20

PLoS ONE

Medicinal ChemistryDrug TargetAnti-her2 AdcsVivo EvaluationMedicine +11

Monoclonal Antibodies to Six-Transmembrane Epithelial Antigen of the Prostate-1 Inhibit Intercellular Communication <i>In vitro</i> and Growth of Human Tumor Xenografts <i>In vivo</i>

Pia M. Challita-Eid, Kendall Morrison, S. Etessami, +8

Cancer Research

AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML

Daniel S. Pereira, Claudia Guevara, Liqing Jin, +18

Molecular Cancer Therapeutics

ImmunologyImmunotherapeuticsImmunotherapyCancer BiologyTumor Biology +16

Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting <i>SLITRK6</i> , a New Urothelial Cancer Biomarker

Kendall Morrison, Pia M. Challita-Eid, Arthur Raitano, +14

Molecular Cancer Therapeutics

Biodegradable Periodic Mesoporous Organosilica (BPMO) Loaded with Daunorubicin: A Promising Nanoparticle‐Based Anticancer Drug

Ngoc Xuan Dat, Albane Birault, Kotaro Matsumoto, +6

ChemMedChem

NanomedicineMedicinal ChemistryDrug TargetingNanotherapeuticsEngineering +13

Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease.

C Kretschmer, David Jones, Kendall Morrison, +7

PubMed

AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma

Fernando Doñate, Arthur Raitano, Kendall Morrison, +18

Clinical Cancer Research

Detection of tumour necrosis factor alpha in sarcoidosis and tuberculosis granulomas using in situ hybridisation.

Nyree Myatt, G Coghill, Kendall Morrison, +2

Journal of Clinical Pathology

The Discovery and Preclinical Development of ASG-5ME, an Antibody–Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer

Michael Mattie, Arthur Raitano, Kendall Morrison, +20

Molecular Cancer Therapeutics